Remepy
Develops Hybrid Drugs combining prescription medicines with AI-driven therapeutic apps
$36MSeries A
Role not disclosedQC
Qumra Capital
Activity from announced rounds
Activity in this selectionAug 31, 2026 · Aug 1, 2026
Qumra Capital is the investment firm identified by Remepy and in Buildots’ issuer financing announcement.
Recorded funding activity
Buildots measures construction progress from site imagery. Remepy combines medicines with therapeutic applications, while QuantHealth simulates trials before enrollment. The recorded activity does not assign a particular unnamed fund.
Sources
- Rounds participated in
- 3
- Confirmed lead rounds
- — 3 roles undisclosed
- New companies
- 3 First participation on record · 0 follow-on
- Funding in participating rounds
- $206M 3 disclosed · full round size, not this investor’s share
By stage
By primary sector
By country
Rounds
3 in this selectionQuantHealth
AI-driven platform that simulates clinical trials to predict outcomes before patient enrollment
$45MSeries B
Role not disclosedZenity
AI security and governance platform purpose-built for enterprise AI agents
$125MSeries C
Role not disclosed